View in EDS

Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study

Saved in:
Bibliographic Details
Title: Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study
Authors: Vera, Pierre1 pierre.vera@rouen.fnclcc.fr, Bohn, Pierre1 pbohn@rouen.fnclcc.fr, Edet-Sanson, Agathe1 aedetsanson@rouen.fnclcc.fr, Salles, Alice1 shapdey@rouen.fnclcc.fr, Hapdey, Sebastien1 rmodzelewski@rouen.fnclcc.fr, Gardin, Isabelle1 igardin@rouen.fnclcc.fr, Ménard, Jean-François2 jean-francois.menard@univ-rouen.fr, Modzelewski, Romain1, Thiberville, Luc3 Luc.Thiberville@univ-rouen.fr, Dubray, Bernard4 bdubray@rouen.fnclcc.fr
Source: Radiotherapy & Oncology. Jan2011, Vol. 98 Issue 1, p109-116. 8p.
Subjects: Cancer radiotherapy, Lung cancer treatment, Cancer tomography, Metabolism, Glucose, Hypoxemia, Analysis of variance, Statistical correlation, Thymidine
Abstract: Abstract: Objectives: To investigate the changes in tumour proliferation (using FLT), metabolism (using FDG), and hypoxia (using F-miso) during curative (chemo-) radiotherapy (RT) in patients with non-small-cell lung cancer (NSCLC). Patients and methods: Thirty PET scans were performed in five patients (4 males, 1 female) that had histological proof of NSCLC and were candidates for curative-intent RT. Three PET-CT (Biograph S16, Siemens) scans were performed before (t 0) and during (around dose 46Gy, t 46) RT with minimal intervals of 48h between each PET-CT scan. The tracers used were 18fluoro-2deoxyglucose (FDG) for metabolism, 18fluorothymidine (FLT) for proliferation, and 18F-misonidasole (F-miso) for hypoxia. The 3 image sets obtained at each time point were co-registered (rigid: n =9, elastic: n =1, Leonardo, TrueD, Siemens) using FDG PET-CT as reference. VOIs were delineated (40% SUVmax values were used as a threshold) for tumours and lymph nodes on FDG PET-CT, and they were automatically pasted on FLT and F-miso PET-CT images. ANOVA and correlation analyses were used for comparison of SUVmax values. Results: Four tumours and twelve nodes were identified on initial FDG PET-CT images. FLT SUVmax values were significantly lower (p <0.0006) at t 46 in both tumours and nodes. The decrease in FDG SUVmax values had a trend towards significance (p =0.048). F-Miso SUVmax values were significantly higher in tumours than in nodes (p =0.02) and did not change during radiotherapy (p =0.39). A significant correlation was observed between FLT and FDG uptake (r =0.56, p <10−4) when all data were pooled together, and they remained similar when the before and during RT data were analysed separately. FDG and F-miso uptakes were significantly correlated (r =0.59, p =0.0004) when all data were analysed together. The best fit was obtained after adjusting for lesion type (tumour vs. node). This correlation was observed for the SUVmax measured during RT (r =0.70, p =0.008) but not for the pre-RT data (r =0.19, p =0.35). The weak correlation between FLT and F-miso uptakes only became significant (r =0.66, p =0.002) when the analysis was restricted to the data acquired during RT. Conclusion: Three different PET acquisitions can be performed quasi-simultaneously (4–7days) before and during radiotherapy in patients with NSCLC. Our results at 46Gy suggest that a fast decrease in the proliferation of both tumours and nodes exists during radiotherapy with differences in metabolism (borderline significant decrease) and hypoxia (stable). [Copyright &y& Elsevier]
Copyright of Radiotherapy & Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
FullText Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 57368649
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Simultaneous positron emission tomography (PET) assessment of metabolism with &lt;superscript&gt;18&lt;/superscript&gt;F-fluoro-2-deoxy-d-glucose (FDG), proliferation with &lt;superscript&gt;18&lt;/superscript&gt;F-fluoro-thymidine (FLT), and hypoxia with &lt;superscript&gt;18&lt;/superscript&gt;fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Vera%2C+Pierre%22&quot;&gt;Vera, Pierre&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; pierre.vera@rouen.fnclcc.fr&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Bohn%2C+Pierre%22&quot;&gt;Bohn, Pierre&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; pbohn@rouen.fnclcc.fr&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Edet-Sanson%2C+Agathe%22&quot;&gt;Edet-Sanson, Agathe&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; aedetsanson@rouen.fnclcc.fr&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Salles%2C+Alice%22&quot;&gt;Salles, Alice&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; shapdey@rouen.fnclcc.fr&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hapdey%2C+Sebastien%22&quot;&gt;Hapdey, Sebastien&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; rmodzelewski@rouen.fnclcc.fr&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gardin%2C+Isabelle%22&quot;&gt;Gardin, Isabelle&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; igardin@rouen.fnclcc.fr&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22M&#233;nard%2C+Jean-Fran&#231;ois%22&quot;&gt;M&#233;nard, Jean-Fran&#231;ois&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;i&gt; jean-francois.menard@univ-rouen.fr&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Modzelewski%2C+Romain%22&quot;&gt;Modzelewski, Romain&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Thiberville%2C+Luc%22&quot;&gt;Thiberville, Luc&lt;/searchLink&gt;&lt;relatesTo&gt;3&lt;/relatesTo&gt;&lt;i&gt; Luc.Thiberville@univ-rouen.fr&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Dubray%2C+Bernard%22&quot;&gt;Dubray, Bernard&lt;/searchLink&gt;&lt;relatesTo&gt;4&lt;/relatesTo&gt;&lt;i&gt; bdubray@rouen.fnclcc.fr&lt;/i&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Radiotherapy+%26+Oncology%22&quot;&gt;Radiotherapy &amp; Oncology&lt;/searchLink&gt;. Jan2011, Vol. 98 Issue 1, p109-116. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Cancer+radiotherapy%22&quot;&gt;Cancer radiotherapy&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Lung+cancer+treatment%22&quot;&gt;Lung cancer treatment&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Cancer+tomography%22&quot;&gt;Cancer tomography&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Metabolism%22&quot;&gt;Metabolism&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Glucose%22&quot;&gt;Glucose&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Hypoxemia%22&quot;&gt;Hypoxemia&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Analysis+of+variance%22&quot;&gt;Analysis of variance&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Statistical+correlation%22&quot;&gt;Statistical correlation&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Thymidine%22&quot;&gt;Thymidine&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Abstract: Objectives: To investigate the changes in tumour proliferation (using FLT), metabolism (using FDG), and hypoxia (using F-miso) during curative (chemo-) radiotherapy (RT) in patients with non-small-cell lung cancer (NSCLC). Patients and methods: Thirty PET scans were performed in five patients (4 males, 1 female) that had histological proof of NSCLC and were candidates for curative-intent RT. Three PET-CT (Biograph S16, Siemens) scans were performed before (t 0) and during (around dose 46Gy, t 46) RT with minimal intervals of 48h between each PET-CT scan. The tracers used were 18fluoro-2deoxyglucose (FDG) for metabolism, 18fluorothymidine (FLT) for proliferation, and 18F-misonidasole (F-miso) for hypoxia. The 3 image sets obtained at each time point were co-registered (rigid: n =9, elastic: n =1, Leonardo, TrueD, Siemens) using FDG PET-CT as reference. VOIs were delineated (40% SUVmax values were used as a threshold) for tumours and lymph nodes on FDG PET-CT, and they were automatically pasted on FLT and F-miso PET-CT images. ANOVA and correlation analyses were used for comparison of SUVmax values. Results: Four tumours and twelve nodes were identified on initial FDG PET-CT images. FLT SUVmax values were significantly lower (p &lt;0.0006) at t 46 in both tumours and nodes. The decrease in FDG SUVmax values had a trend towards significance (p =0.048). F-Miso SUVmax values were significantly higher in tumours than in nodes (p =0.02) and did not change during radiotherapy (p =0.39). A significant correlation was observed between FLT and FDG uptake (r =0.56, p &lt;10−4) when all data were pooled together, and they remained similar when the before and during RT data were analysed separately. FDG and F-miso uptakes were significantly correlated (r =0.59, p =0.0004) when all data were analysed together. The best fit was obtained after adjusting for lesion type (tumour vs. node). This correlation was observed for the SUVmax measured during RT (r =0.70, p =0.008) but not for the pre-RT data (r =0.19, p =0.35). The weak correlation between FLT and F-miso uptakes only became significant (r =0.66, p =0.002) when the analysis was restricted to the data acquired during RT. Conclusion: Three different PET acquisitions can be performed quasi-simultaneously (4–7days) before and during radiotherapy in patients with NSCLC. Our results at 46Gy suggest that a fast decrease in the proliferation of both tumours and nodes exists during radiotherapy with differences in metabolism (borderline significant decrease) and hypoxia (stable). [Copyright &amp;y&amp; Elsevier]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Radiotherapy &amp; Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=57368649
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.radonc.2010.10.011
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 109
    Subjects:
      – SubjectFull: Cancer radiotherapy
        Type: general
      – SubjectFull: Lung cancer treatment
        Type: general
      – SubjectFull: Cancer tomography
        Type: general
      – SubjectFull: Metabolism
        Type: general
      – SubjectFull: Glucose
        Type: general
      – SubjectFull: Hypoxemia
        Type: general
      – SubjectFull: Analysis of variance
        Type: general
      – SubjectFull: Statistical correlation
        Type: general
      – SubjectFull: Thymidine
        Type: general
    Titles:
      – TitleFull: Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vera, Pierre
      – PersonEntity:
          Name:
            NameFull: Bohn, Pierre
      – PersonEntity:
          Name:
            NameFull: Edet-Sanson, Agathe
      – PersonEntity:
          Name:
            NameFull: Salles, Alice
      – PersonEntity:
          Name:
            NameFull: Hapdey, Sebastien
      – PersonEntity:
          Name:
            NameFull: Gardin, Isabelle
      – PersonEntity:
          Name:
            NameFull: Ménard, Jean-François
      – PersonEntity:
          Name:
            NameFull: Modzelewski, Romain
      – PersonEntity:
          Name:
            NameFull: Thiberville, Luc
      – PersonEntity:
          Name:
            NameFull: Dubray, Bernard
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2011
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-print
              Value: 01678140
          Numbering:
            – Type: volume
              Value: 98
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Radiotherapy & Oncology
              Type: main
ResultId 1